LIFECORE BIOMEDICAL, INC. Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net
LIFECORE BIOMEDICAL, INC. (LFCR) reported Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net of $793.00 thousand for the 12-month period ending 2015-05-31, per its 10-K/A filed 2018-03-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherThanTemporaryImpairmentLossesInvestmentsPortionRecognizedInEarningsNet · last filed 2018-03-15
- LIFECORE BIOMEDICAL, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for the quarter ending 2015-05-31 was $0.00.
- LIFECORE BIOMEDICAL, INC. other than temporary impairment losses, investments, portion recognized in earnings, net for fiscal 2015 was $793.00K.
| Period end | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 3 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 9 month | Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net 12 month |
|---|---|---|---|
| 2015-05-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $793.00K 10-K/A · filed 2018-03-15 | |
| 2015-03-01 | $793.00K 10-Q · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |